Cancer trials T-DXd outperforms T-DM1 in the second-line treatment of HER2+ metastatic breast cancer Read more
Cancer trials Futibatinib demonstrates clinical benefit in FGFR2-rearranged intrahepatic cholangiocarcinoma Read more
Cancer trials Longer follow-up solidifies adjuvant abemaciclib plus endocrine therapy as standard of care fo... Read more
Cancer trials Adagrasib with or without cetuximab effective in patients with colorectal cancer with mutated ... Read more
Cancer trials Capivasertib plus fulvestrant improves clinical outcomes in advanced breast cancer Read more
Cancer trials Modified FOLFIRINOX improves survival outcomes for patients with pancreatic cancer Read more